Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    ES15 - Is Cytotoxic Chemotherapy in NSCLC Management Only Palliative?

    • 15:45 - 16:45
    • 8/07/2022
    • Location: Strauss 1/2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
    • +

      Session Moderator

      16:40 - 16:45  |  Presenter: Navneet Singh

      • Abstract

      Loading...

    • +

      Session Moderator

      16:40 - 16:45  |  Presenter: Khaled Abdel-Aziz Mohamed Kamal

      • Abstract

      Loading...

    • +

      ES15.01 - Session Introduction

      15:45 - 15:46  |  Presenter: Navneet Singh

      • Abstract

      Loading...

    • +

      ES15.02 - Session Introduction

      15:46 - 15:47  |  Presenter: Khaled Abdel-Aziz Mohamed Kamal

      • Abstract

      Loading...

    • +

      ES15.03 - Impact of Smoking on Clinical Outcomes of Systemic Therapies

      15:47 - 15:52  |  Presenter: Enrica Capelletto

      • Abstract

      Loading...

    • +

      ES15.04 - Can Chemotherapy Agents Be Personalized in NSCLC?

      15:52 - 16:04  |  Presenter: David Planchard

      • Abstract

      Loading...

    • +

      ES15.05 - Second-Line Chemotherapy Following First-Line Mono-Immunotherapy in High PD-L1 (TPS≥50%) Advanced/Metastatic NSCLC

      16:04 - 16:16  |  Presenter: Sara Pilotto

      • Abstract

      Loading...

    • +

      ES15.06 - The Future of Cytotoxics in the Management of NSCLC

      16:16 - 16:28  |  Presenter: Sofia Baka

      • Abstract

      Loading...

    • +

      ES15.07 - Chemotherapy in Elderly NSCLC Patients: How to Play It Safe?

      16:28 - 16:40  |  Presenter: Rajwanth Veluswamy

      • Abstract

      Loading...

    • +

      ES15.08 - Live Q&A

      16:40 - 16:45

      • Abstract

      Loading...